Following a Supreme Court setback, President Trump is directing new Section 301 investigations against trading partners. These probes, covering industrial policies to drug pricing, empower the USTR to enforce trade rights and respond to unfair practices. Past actions have led to significant tariff impositions, particularly on China, with ongoing reviews and new investigations initiated.